Novoheart to Acquire Xellera Therapeutics
28 mai 2019 10h47 HE
|
Novoheart Holdings Inc.
Xellera Therapeutics Limited will accelerate the progression of Novoheart’s current business scopeSignificantly enhances Novoheart’s liquidity, gaining access to approximately C$22,500,000 cash ...
Novoheart Holdings Inc. Reports Third Quarter 2019 Financial Results and Stock Option Grants
17 mai 2019 17h00 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and nine months ended March 31, 2019....
Novoheart Announces Revolving Credit Facility
11 avr. 2019 02h45 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, April 10, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that its subsidiary, Novoheart Limited (Hong...
Novoheart Grants Stock Options
06 mars 2019 20h00 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, March 06, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that it has granted incentive stock options to...
Novoheart Holdings Inc. Reports Second Quarter 2019 Financial Results and Announces AGM Results
01 mars 2019 19h50 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, March 01, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and six months ended December 31, 2018....
Novoheart Grants Stock Options and RSUs
08 févr. 2019 17h43 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that it has granted incentive stock options to...
Novoheart Provides Corporate Update
07 janv. 2019 08h00 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announced today that Iris Lo has tendered her resignation...
Novoheart Holdings Inc. Reports First Quarter 2019 Financial Results
22 nov. 2018 20h21 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three months ended September 30, 2018....
Novoheart to Generate USD $1.7m From Strategic Partnership to Build Good Manufacturing Practice Facility to Create Clinical-Grade Human Stem Cell Libraries
31 oct. 2018 04h42 HE
|
Novoheart Holdings Inc.
Phase 1 (6 to 9 months) of potential multi-year effort Service agreement to generate US$1.7M of revenue Novoheart will have exclusive rights to the iPSC cell lines for cardiac applicationsPartnership...
Novoheart Recruits Notable Pharma Industry Executive, Bernard Fermini, Ph.D. as Chief R&D Officer
24 sept. 2018 03h05 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, announced today that it has...